Another HSV-basedoncolytic virus οHSV G47Δ, engineered to deliver IL-12, induced long-term durablecures in two syngeneic mouse models of GBM, when combined with anti-CTLA-4 andanti-PD-1 treatment. Here, CTLA4 is linked to glioblastoma.